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license (http://creativecommons.org/licenseAbstract Background: Adequate sleep improves physical and mental alertness. However,
there is a dearth of empirical data on functional capacity (FC) and sleep quality (SpQ) in
patients with chronic heart failure (CHF).
Objective: This study investigated the relationship between FC and SpQ of patients with CHF
and apparently healthy controls (HCs).
Methods: This case-control study recruited 50 patients with CHF whose left ventricular ejec-
tion fraction (LVEF) was <40%, attending cardiac clinics of selected government hospitals in
Osun State. Furthermore, 50 age- and sex-matched healthy individuals were recruited as con-
trols. Socio-demographic characteristics and cardiovascular parameters were assessed. The FC
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18 T.O. Awotidebe et al.Quality Index (PSQI), respectively. Data were analysed using descriptive and inferential statis-
tics. Alpha level was set at p < 0.05.
Results: Patients had a significantly lower FC and poorer SpQ than HCs, 4.6  0.5 versus
11.3  1.6 mL/kg/min (t Z 3.452; p Z 0.001) and 8.74  1.6 versus 3.8  1.3 (t Z
5.371; p Z 0.001), respectively. HCs were about five times more likely to walk longer dis-
tance [odds ratio (OR), 4.8; confidence interval (CI), 2.0e11.1] and had a better heart rate
(OR, 2.8; CI, 1.4e5.3) than patients. SpQ had a significant negative correlation with FC of pa-
tients (r Z 0.362; p Z 0.001) but a significant positive correlation with HCs (r Z 0.481;
pZ 0.041). Furthermore, there were significant correlations between FC and body mass index
in both groups (CHF: r Z 0.247, p Z 0.022; HCs: r Z 0.321, p Z 0.040).
Conclusion: Patients with heart failure demonstrated lower functional capacity and poorer
sleep quality.
Copyright ª 2016, Hong Kong Physiotherapy Association. Published by Elsevier (Singapore) Pte
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
The prevalence of chronic heart failure (CHF) is on the rise
due to ageing population and improved medical and
healthcare services worldwide [1,2]. Surprisingly, the
mortality rate from CHF is still high despite recent advances
in treatment and care [3]. In sub-Saharan Africa, the
epidemiological transition from communicable diseases to
chronic non-communicable diseases has contributed to high
prevalence of cardiovascular disease, including CHF [4].
Although the actual prevalence of CHF is unknown in
Nigeria, reports from hospital admissions and mortality
rates have shown that prevalence of CHF is on the increase
according to Adedoyin and Adesoye [5] and Ojji et al [6]
reporting prevalence rates of 3.5% and 4.3%, respectively.
Chronic heart failure is characterized by progressive
fatigue, pedal and abdominal oedema, and exertion dysp-
noea during minimal exercise and then later on progresses
to dyspnoea at rest [7,8]. Furthermore, patients with CHF
usually experience a characteristic breathing pattern called
CheyneeStokes respiration [9]. It is a series of increasingly
deep breaths followed by a brief cessation of breathing,
thus causing sleep-disordered breathing (SDB), including
obstructive sleep apnoea (OSA) or central sleep apnoea
(CSA), which often leads to poor sleep quality (SpQ)
[10,11]. Sharma et al [12] also confirmed that poor SpQ
further complicates CHF by contributing to hypertension,
myocardial infarction, stroke, and nocturnal arrhythmias
that could be very deleterious in patients with CHF.
Sleep complaints are common in patients with CHF and
may include fragmentation of sleep and excessive daytime
sleepiness [11]. Sleep disorder may affect functional per-
formance causing fatigue and confusion and leading to a
vicious cycle of poor health status and worsening prognosis.
It may also predict mortality [13]. Due to progressive
deconditioning and persistent poor SpQ commonly seen in
patients with CHF, regular assessment of SpQ and func-
tional capacity have become imperative in order to identify
patients at risk and provide a better guide to therapeutic
procedures for effective rehabilitation. It is now evident
that the treatment of sleep disorder requires a multidisci-
plinary approach in order to enhance prognosis [14,15].Functional capacity is the ability of the body to utilize
oxygen and a known measure of cardiorespiratory fitness,
as well as a strong predictor of survival in CHF. Oxygen
deprivation during sleep may have negative consequences
on the cardiovascular health of patients with CHF. Although
studies have shown that improvement in functional capac-
ity has direct and multiplier effects on cardiovascular
health in patients with CHF [16,17], the relationship be-
tween sleep quality and functional capacity remains un-
clear. More importantly, few studies have examined the
relationship between SpQ and functional capacity in
Nigerian patients with CHF and compared with apparently
healthy controls. A priori, we hypothesized that patients
with CHF have a different SpQ compared to healthy sub-
jects, which is related to low functional capacity inde-
pendent of severity of the cardiac condition. This study
investigated the relationship between SpQ and functional
capacity of Nigerian patients with CHF and apparently
healthy controls.Methods
Participants and setting
This is a case-control study that employed purposive sam-
pling technique to recruit 50 patients (16 male and 34 fe-
male) with chronic heart failure (CHF) who were receiving
treatment at the cardiac care units of selected government
hospitals in Osun State. Furthermore, 50 apparently healthy
individuals (20 males and 30 females) were recruited as
controls. The sample size for this study was based on
comparative research studies comparing two equal groups
as advanced by Eng [18]. The sample size formula goes
thus: N Z [4s2(zcrit þ zpwr)2]/D2, where N is the total
sample size (the sum of the sizes of both comparison
groups), s is the assumed standard deviation (SD) of each
group (assumed to be equal for both groups), the zcrit value
is the desired significance criterion, z-value (z-value for 95%
confidence level, 1.96), while the zpwr value is the desired
statistical power, 80% (0.842). D is the minimum expected
difference (effect size) between the two means of primary
19outcome (sleep quality). According to Lewith et al [19] in a
previous study, an effect size of 3 points and an SD of 1.2 on
PSQI were considered to be clinically significant in patients
with sleep disturbance. Thus, the equation above yielded a
sample size of N Z 50.2. Therefore, a total of 50 partici-
pants (rounding N to the nearest whole number) were to be
recruited. However, the sample size was doubled to 100,
comprising 50 patients with CHF and 50 age- and sex-
matched apparently healthy individuals as controls. This
was done with the view to improving the validity of the
results.
Inclusion and exclusion criteria
Eligibility for inclusion were clinical diagnosis of stable CHF
in stage II or III [New York Heart Association (NYHA) func-
tional classification]. The left ventricular ejection fraction
(LVEF) was less than 40% obtained from the echographic
assessment. Participants whose ages were 40 years and
older and attending cardiac care units of selected govern-
ment hospitals in Osun State, namely Ife Hospital Unit, Ile-
Ife, and Wesley Guild Hospital, Ilesha, of the Obafemi
Awolowo University Teaching Hospitals Complex and
Ladoke Akintola University of Technology Teaching Hospi-
tal, Osogbo. In addition, age- and sex-matched apparently
healthy controls were recruited among hospital staff and
patients’ relatives. They were excluded from the study if
they had presented with self-reported unstable angina
during the previous months, musculoskeletal problems that
significantly limit walking and comorbidities such as type 2
diabetes neuropathy, neurological condition, depressive
symptoms, and cognitive disorders. Ethical approval for the
study was sought and obtained from the Health Research
and Ethics Committee of the Institute of Public Health
(IPH/OAU/12/428), Obafemi Awolowo University, Ile-Ife,
Osun State, Nigeria.
Procedures
Permission to recruit participants into the study was sought
from the unit heads in charge of cardiac care clinics in the
selected government hospitals with an explanation of the
purpose of the study. The purpose and procedures of the
study were explained to the participants and written
informed consent was obtained. Anthropometric charac-
teristics including weight, height, and body mass index
(BMI) were assessed while cardiovascular parameters
including heart rate, systolic and diastolic blood pressure
were measured in sitting position using an electronic
sphygmomanometer (Omron Intelli Sense M6 Comfort,
Japan). The Pittsburgh Sleep Quality Index (PSQI) was
administered to assess sleep quality and functional capac-
ity was assessed using the 6-minute walk test (6MWT).
Assessment of sleep quality
Sleep quality of participant was assessed using the PSQI.
The questionnaire consisted of two sections: the first sec-
tion sought information on participants’ bio-data including
age, sex, and occupation, while the second section sought
information on sleep quality. The PSQI was developed byBuysse et al [20] and is a self-reported index that assesses
sleep quality during the previous month. It has 19 items,
each of which is scored equally between 0 and 3. The index
contains seven subscales evaluating subjective sleep qual-
ity, sleep latency, sleep duration, habitual sleep efficiency,
sleep disturbances, use of sleeping medications, and day-
time dysfunction. The seven component scores are then
summed to yield a global PSQI score, which has a range of
0 to 21. Scores greater than 5 were considered poor, as
higher scores indicate worse sleep quality [20].
The psychometric properties of the instrument were
determined by translating the original PSQI to Yoruba lan-
guage and back translated to English language by experts.
The translation was done by Yoruba language experts and
another English expert for back translation in the Depart-
ment of Linguistics and African Languages Studies of the
Obafemi Awolowo University, Ile-Ife, Nigeria. The original
version was administered on five patients with CHF and five
age- and sex-matched healthy controls who were not part of
the main study. After 1 week, the new English version was
readministered on the same participants. Responses from
the original and new version were subjected to testeretest
reliability using Spearman rank correlation coefficient. A
testeretest reliability value of r Z 0.72 was obtained. The
questionnaire was self-administered and was collected
immediately after completion. However, participants who
were not literate in the English language were assisted by a
research assistant who translated and read the question
aloud to the participant before an option was chosen.
Assessment of functional capacity
The 6-MWT was conducted using a standardized procedure
according to the American Thoracic Society [21]. A 30-m
corridor within the cardiac care unit of the hospital was
marked out by two cones for the test. Participants were
allowed to rest for a period of 10 minutes in a sitting po-
sition before the commencement of the exercise test. Pa-
tients were instructed to walk from the starting point to the
end at their own selected pace while attempting to cover as
much ground as possible in 6 minutes. They were encour-
aged every 30 seconds or so in a standardized manner [22].
Rate of perceived exertion was assessed while cardiovas-
cular parameters were recorded immediately after the 6-
MWT. The total distance walked in 6-minutes was recor-
ded to the nearest meter and functional capacity
(maximum oxygen consumption, VO2 max) was estimated
using a predictive equation [23].
Statistical analysis
Descriptive statistics of frequency, mean, and standard de-
viation were used to summarize data. Independent t-test
was used to determine the difference in age, physical
characteristics, and cardiovascular parameters between
patients and healthy controls. Furthermore, as appropriate,
the independent t-test or ManneWhitney U-test were used
to compare functional capacity and sleep quality between
male and female patients and healthy controls. Analysis of
covariance (ANCOVA) was conducted to compare the SpQ of
patients with CHF and healthy controls using systolic blood
Table 1 Socio-demographic characteristics and clinical
profile of all participants.
Variable Patient (n Z 50) Control (n Z 50)
n % n %
Sex
Male 16 32.0 20 40.0
Female 34 68.0 30 60.0
Age group (year)
40e50 14 28.0 34 68.0
51e60 19 38.0 10 20.0
>60 17 34.0 6 12.0
Occupation
Artisan 22 44.0 14 28.0
Civil servant 11 22.0 18 36.0
Retiree 10 20.0 8 16.0
Self-employed 7 14.0 10 20.0
Educational status
Primary school 18 36.0 9 18.0
Secondary school 21 42.0 8 16.0
Tertiary school 11 22.0 23 46.0
NYHA functional class
Class II 32 64.0 __ __
Class III 18 36.0 __ __
CHF diagnosis
Ischemic heart disease 5 10.0 __ __
Dilated cardiomyopathy 7 14.0 __ __
Hypertensive heart disease 18 36.0 __ __
Idiopathic 20 40.0 __ __
Medicationsa
ACE-I or ARB 21 24.0 __ __
Diuretic 22 44.0 __ __
b-Blocker 9 18.0 __ __
Digoxin 8 16.0 __ __
Aspirin 41 82.0 __ __
CCA 1 2.0 __ __
ACE-I Z angiotensin-converting enzyme inhibitor; ARB Z
angiotensin receptor blocker; CCA Z calcium channel antago-
nist; CHF Z chronic heart failure; NYHA Z New York Heart
Association.
a Values may not sum to 100.0% due to combination of drugs.
20 T.O. Awotidebe et al.pressure (SBP), diastolic blood pressure (DBP), and BMI as
covariates. Multivariate unconditional logistic regression
models were used to obtain odds ratio (OR) estimates with
95% confidence intervals (CI) on SpQ. Similarly, as appro-
priate, Pearson’s product moment correlation or Spearman
rank correlation test were used to test the relationship be-
tween sleep quality, functional capacity, and BMI of patients
and healthy controls. SPSS version 19 (IBM Corp., Armonk,
NY, USA) was used for the data analysis. Alpha level was set
at p < 0.05 of significance [23].
Computation: VO2 max Z walking distance/
6 min  0.1 þ 3.5 mL/kg/min
Results
The socio-demographic characteristics and clinical profiles
of all participants are presented in Table 1. All participants
were comparable in age and physical characteristics
(p > 0.05) except BMI (p < 0.05). Furthermore, there were
significant differences in all cardiovascular parameters
between patients and healthy controls in pre-6MWT and
post-6MWT (p < 0.05; Table 2). Table 3 shows the rela-
tionship between SpQ and covariates (SBP, DBP, and BMI).
There were significant effects of covariates on SpQ. The
partial h2 with an effect size of 0.4148 shows that the
proportion of variation in the sleep quality score due to
covariates accounts for about 42% of the variation. Table 4
shows the comparison of functional capacity and sleep
quality of patients and healthy controls. There were sig-
nificant differences between 6MWD and estimated VO2 max
between patients and healthy controls: 242.4  30.1 m
versus 467.1  65.6 m (t Z 3.452; p Z 0.001) and
4.62  0.50 mL/kg/min versus 11.3  1.6 mL/kg/min
(t Z 3.452; p Z 0.001), respectively. Furthermore,
comparison of the sleep quality scores of male and female
patients with CHF showed significant difference in the PSQI
score between male and female patients with CHF:
6.6  3.6 versus 7.4  3.3 (t Z 3.275; p Z 0.026),
respectively (Table 5).
Table 6 shows amultivariate analysis in relation with SpQ,
functional capacity, and cardiovascular parameters.
Healthy controls were approximately five times more likely
to walk longer distance (OR, 4.8; CI, 2.0e11.1) and had a
better heart rate (OR, 2.8; CI, 1.4e5.3) than patients with
CHF. The relationship between functional capacity and SpQ
(PSQI total) in the patient group shows negative significant
correlation (rZ 0.362; pZ 0.001) but positive significant
correlation among healthy controls (rZ 0.481; pZ 0.041).
There were significant but inverse correlations between
each SpQ sub-score and functional capacity (p < 0.05).
Functional capacity had a positive significant correlation
with bodymass index for both patient (rZ 0.247; pZ 0.022)
and control (rZ 0.321; pZ 0.001) groups (Table 7).
Discussion
The purpose of this study was to investigate the functional
capacity and SpQ of patients with CHF and their relation-
ships and also compare with apparently healthy individuals.Findings from our study show that the functional capacity
of patients with CHF was significantly lower than healthy
controls. This finding is consistent with that of previous
studies in which patients with CHF were reported to have
lower functional capacity compared with healthy controls
[24,25]. The plausible explanation for the difference be-
tween patients and healthy controls may be as a result of
the underlying pathology caused by heart failure itself.
Patients with CHF are known to have poor muscular
strength due to changes in the anatomical and physiological
structures in the skeletal muscles leading to increasing
muscle flaccidity, easy fatigability, extracellular fluid
accumulation, dyspnoea, and SDB [8,13,26]. Furthermore,
comparison of the findings of the mean functional capacity
from our study indicated a lower functional capacity
compared to findings of some previous studies [16,17]. The
disparity might be due to individual differences, disease
Table 2 Comparison of physical characteristics, pre- and
post-6-minute walk test cardiovascular parameters of pa-
tient and control groups.
Variables Patient
(n Z 50)
Mean  SD
Control
(n Z 50)
Mean  SD
t-cal p value
Age (years) 57.8  8.9 54.9  7.9 1.94 0.062
Weight (kg) 70.4  11.7 66.2  11.1 1.57 0.121
Height (m) 1.51  0.2 1.53  0.1 1.66 0.100
BMI (kg/m2) 30.4  7.0 28.6  6.3 2.10 0.042*
WHR 0.8  0.4 0.8  0.1 1.63 0.113
Pre-6MWT
SBP (mmHg) 131.9  22.1 121.9  14.2 2.897 0.001*
DBP (mmHg) 82.2  13.3 78.0  13.5 2.091 0.042*
HR (bpm) 80.0  14.4 72.2  11.2 2.880 0.001*
Post-6MWT
SBP (mmHg) 138.4  21.1 128.9  12.5 2.263 0.001*
DBP (mmHg) 86.1  13.1 79.1  14.5 0.981 0.001*
HR (bpm) 77.9  13.9 75.9  11.3 2.465 0.024*
*p < 0.05.
6MWT Z 6-minute walk test; BMI Z body mass index;
DBP Z diastolic blood pressure; HC Z hip circumference;
HRZ heart rate; SBPZ systolic blood pressure; SDZ standard
deviation; WC Z waist circumference; WHR Z waist-to-hip
ratio.
Table 3 Results of ANCOVA comparing sleep quality be-
tween patients with CHF and apparently healthy controls.
Source Partial SS df MS F p value
Model 35556.06 4 8889.02 1790.69 0.001*
SBP 327.07 2 163.53 32.94 0.001*
DBP 42.97 1 42.97 8.66 0.003*
BMI 3600.92 1 3600.92 725.41 0.001*
Residual 570.86 115 4.96
Total 36126.93 119 303
Partial h2 0.4148
Adjusted R2 0.9836
*p < 0.05.
BMI Z body mass index; DBP Z diastolic blood pressure;
df Z degrees of freedom; MS Z mean of squares;
SBP Z systolic blood pressure; SS Z sum of squares.
Table 4 Comparison of functional capacity and sleep
quality scores of healthy control and patients with CHF.
Variable Patient Control p value
Mean  SD Mean  SD
6-MWD (m) 242.4  30.1 467.1  65.6 0.001*
Est.VO2 max
(mL/kg/min)
4.62  0.50 11.3  1.6 0.001*
PSQI total 8.7  1.6 3.8  1.3 0.001*
Subj. SpQ 1.4  0.6 0.9  0.2 0.001*
Sleep latency 1.7  0.7 0.8  0.4 0.001*
Sleep duration 1.2  1.0 0.9  0.5 0.001*
Hab. Sp eff. 0.8  0.4 0.4  0.2 0.001*
Sp disturb. 1.8  0.7 1.2  0.5 0.001*
Use Sp med. 0.5  0.2 0.4  0.1 0.058
Daytime dysf. 0.8  0.3 0.3  0.1 0.001*
*p < 0.05.
6-MWD Z 6-minute walk distance; Daytime dysf. Z daytime
dysfunction; Est.VO2 max Z estimated maximum oxygen con-
sumption; Hab. Sp eff. Z habitual sleep efficiency; PSQI Z
Pittsburgh Sleep Quality Index; SD Z standard deviation; Subj.
SpQ Z subjective sleep quality; Use Sp med. Z use of sleep
medication.
Table 5 Comparison of sleep quality scores of male and
female patients with CHF.
Variable Male Female p value
Mean  SD Mean  SD
PSQI total 6.6  3.6 7.4  3.3 0.026*
Subj. SpQ 1.3  0.6 1.4  0.8 0.149
Sleep latency 1.4  0.7 1.7  0.6 0.026*
Sleep duration 1.2  1.0 1.1  0.4 0.371
Hab. Sp eff. 0.6  0.4 0.7  0.4 0.138
Sleep disturbance 1.6  0.7 1.8  0.6 0.001*
Use Sp med. 0.2  0.5 0.7  0.4 0.001*
Daytime dysf. 0.8  0.6 1.2  0.1 0.032*
*p < 0.05.
Daytime dysf. Z daytime dysfunction; Hab. Sp eff. Z habitual
sleep efficiency; PSQI Z Pittsburgh Sleep Quality Index;
SDZ standard deviation; Subj. SpQZ subjective sleep quality;
Use Sp med. Z use of sleep medication.
21progression, and procedures for the assessment of func-
tional capacity. Also, several factors, including but not
limited to mood of the patients, differences in body weight,
and medications prescribed, might account for the varia-
tions in functional capacity assessment. Nonetheless, the
finding of lower functional capacity implies that patients
with CHF are at higher risk of morbidity and mortality
compared to healthy individuals. Functional capacity is
known to be a strong predictor of survival and a determi-
nant of reduced hospitalization in patients with cardiac
challenges.
Our findings show that the mean PSQI score for SpQ of
patients with CHF is higher than that of healthy controls.
This is in agreement with findings of previous studies that
patients with CHF experienced poorer SpQ [13,27].Furthermore, sleep disorders have been described as a
persistent, major concern among patients with CHF
[11,27]. This implies that sleep disturbances and frequent
waking is a precursor for poor SpQ and a deteriorating
health situation in patients with CHF. In addition, Khayat
et al [13] reported that overall poor SpQ and excessive
daytime sleepiness are strong predictors of mortality in
patients with acute heart failure. Sleep is a naturally
recurring state and involves changes in brain wave activ-
ity, breathing, heart rate, body temperature, and other
physiological functions [28]. It implies that alteration in
SpQ increases the risk of poor prognosis and premature
death [14,27].
Findings from our study also show that female patients
with CHF reported poorer SpQ than their male counterparts.
Table 6 Multivariate analysis of effect of sleep quality on
functional capacity and cardiovascular parameters in pa-
tients with CHF and healthy controls.
Variable
Patient Control
OR (95% CI) OR (95% CI)
6-MWD (m) 0.6 (0.8e1.6)* 4.8 (2.0e11.1)*
Est.VO2 max (mL/kg/min) 0.8 (0.3e35.9)* 3.2 (0.8e1.8)*
SBP (mmHg) 0.4 (0.6e1.0) 1.8 (1.0e3.2)
DBP (mmHg) 1.1 (0.6e2.0) 1.3 (0.9e1.9)
HR (beat/min) 0.9 (0.4e2.1)* 2.8 (1.4e5.3)*
*p < 0.05.
6-MWD Z 6-minute walk distance; CI Z confidence interval;
DBP Z diastolic blood pressure; Est.VO2 max Z estimated
maximum oxygen consumption; HR Z heart rate; OR Z odds
ratio; SBP Z systolic blood pressure.
Table 7 Pearson product moment correlation between
functional capacity, sleep quality, and body mass index of
patient and control groups.
Variable Functional capacity, r (p value)
Patient Control
PSQI total 0.362 (0.001) ** 0.481 (0.041)*
Subjective sleep
quality
0.424 (0.001) ** 0.066 (0.172)
Sleep latency 0.358 (0.001) ** 0.057 (0.248)
Sleep duration 0.121 (0.062) 0.046 (0.163)
Habitual sleep
efficiency
0.284 (0.037)* 0.372 (0.023)*
Sleep disturbances 0.386 (0.001) ** 0.153 (0.031)*
Use of sleeping
medications
0.237 (0.001) ** 0.081 (0.074)
Daytime dysfunction 0.381 (0.001) ** 0.091 (0.062)
BMI (kg/m2) 0.247 (0.022)* 0.321 (0.040)*
*p < 0.05; **p < 0.001.
BMIZ body mass index; PSQIZ Pittsburgh Sleep Quality Index.
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latency, sleep disturbance, use of medication, and daytime
dysfunction among female patients. Contrary to our findings,
a previous study reported that men have higher sleep disor-
ders than women [29]. However, there is a dearth of studies
comparing SpQ betweenmale and female patients with CHF.
Irrespective of gender, it is believed that unrefreshing sleep
is associated with lower physical performance and poor ac-
tivity of daily living, reduced social-relationship perfor-
mances, and increased risk of accidents [30,31].
In our study, we also established that body mass index,
PSQI total score, and all subscores except sleep duration
had inverse significant correlation with functional capacity
in patients with CHF. On the contrary, PSQI total score and
body mass index had a positive significant correlation with
functional capacity. Sharma et al [12] was of the opinion
that obesity may be a marker for narrowing of the upper
airway because of deposition of pharyngeal fat or reduced
end-expiratory lung volume. Although the prevalence of
obesity in patients with CHF is not very high, most patients
being clinically overweight and mildly obese could accountfor SDB, leading to poor SpQ [32,33]. It is also believed that
obesity and age are significant risk factors for poor SpQ like
other patients with OSA. However, the presence of extra-
cellular fluid overload may also increase risk of OSA in pa-
tients with CHF. Also, patients with CHF and OSA usually
have pharyngeal oedema, narrowing of airways and redis-
tribution of fluid from the legs during supine sleep. This
may explain the reason why patients with CHF experience
severe fatigue, reduced physical performance, and poor
SpQ. We also found that there was an inverse significant
relationship between functional capacity and SpQ in pa-
tients with CHF. It implies that the moment SpQ of a patient
begins to deteriorate, functional capacity also worsens.
Although functional capacity alone is an independent pre-
dictor of survival in CHF, presence of poor SpQ could double
the burden or worsen the cardiovascular health outcomes
during rehabilitation. Similarly, Pedrosa et al [34] reported
that lower SpQ is an independent predictor of low quality of
life. Patients with impaired sleep were shown to be inca-
pable of responding quickly to external stimuli due to
reduction in SpQ or quantity, and impaired ability to
perform simple and regular activities of daily living that
may be beneficial to health [35,36].
The current choice of treatment for sleep disorders,
including OSA, is the application of continuous positive
airway pressure (CPAP) [12]. However, clinical results have
shown that many people failed to tolerate the approach
[14,37]. More importantly, addiction to sleep medications is
a challenge in patients undergoing cardiac rehabilitation.
However, there is growing evidence that rehabilitation ex-
ercise is an important adjunct therapy for improving SpQ in
patients with CHF [38,39]. Although physical therapists
often prescribe exercise to ameliorate physical functioning
and improve quality of life, its effects on SpQ have been
well-documented [40,41]. For instance, in a multisite ran-
domized controlled trial study by Suna et al [41] involving
patients with CHF who underwent exercise advice and
another group who received twice weekly structured ex-
ercise training. The authors concluded that 12 weeks of
twice-weekly supervised exercise training improved SpQ in
patients with CHF who were recently discharged from
hospital. Similarly, the beneficial effects of exercise
training on neurovascular function, functional capacity,
and quality of life of patients with systolic dysfunction and
heart failure occurs independently of sleep-disordered
breathing [41,42]. Furthermore, recent studies have also
established that regular participation in physical activity
and exercise training in patients with CHF helps to lessen
the severity of insomnia, obstructive sleep apnoea, and
other sleep disorders [43,44]. Indeed, improvement in
daytime physical activity may stimulate longer periods of
slow-wave sleep, which is the deepest and most restorative
stage of sleep [45].Study Limitations
The PSQI is a self-reported assessment and might be prone
to estimation error and recall bias. However, the instru-
ment was validated prior to the commencement of the
study to ensure its validity and reliability. Future studies
should include an objective measure of sleep quality by
23including polysomnographic or actigraphic assessment.
More importantly, our patients were on different antihy-
pertensive medications and some drugs have been reported
to affect functional capacity, which might confound the
outcome of this study.
Conclusion
Patients with CHF demonstrated lower functional capacity
and poorer sleep quality. The results have important im-
plications for physiotherapy clinicians participating in car-
diac rehabilitation programmes, underscoring the need to
include regular assessment of sleep quality and to include
interventions to improve functional capacity and sleep
quality in patients with CHF.
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